Sydney Jennings

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

ACC.24: Adults with a history of CVD consumed more than double the recommended daily sodium amount, reported researchers.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

The end of another quarter means a new list of FDA-approved drugs for conditions treated in primary care. Are you up-to-date? Click through to find out.

The program, when implemented with support of resident training and tangible tools, reduced parent-reported injuries throughout the first 2 years of life.

Your daily dose of the clinical news you may have missed.

The Low EF AI is designed to detect low ejection fraction in 15 seconds during a primary care exam.

Your daily dose of the clinical news you may have missed.

ACC.24: Data showed that individuals who used e-cigarettes were approximately 19% more likely to develop heart failure compared with those who had never vaped.

Your daily dose of the clinical news you may have missed.

ACC.24: Data showed that participants with ADHD who were prescribed stimulants were 17% more likely to develop cardiomyopathy at 1 year.

Your daily dose of the clinical news you may have missed.

Investigators found vaccine uptake of 41% among unvaccinated individuals who were part of a messaging intervention in the emergency department.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

Longer duration of remission was associated with a greater reduction in CKD and CVD risk, according to a post hoc analysis of the Look AHEAD study.

Your daily dose of the clinical news you may have missed.

ACC.24: Data from an analysis of the CLEAR Outcomes trial showed bempedoic acid was well-tolerated and reduced CV events in Hispanic/Latinx and non-Hispanic/Latinx participants.

Ravi Jhaveri, MD, provides an overview of AstraZeneca's FluMist Quadrivalent vaccine and discusses why it could help increase vaccination rates.

ACC.24: Findings showed a disproportionate distribution of CAC screening that favors White, educated, affluent, English-speaking individuals.

Your daily dose of the clinical news you may have missed.

Submission based on results from the phase 3 QUASAR induction study, which showed statistically significant and clinically meaningful improvements in symptoms.

New research highlights another benefit of COVID-19 vaccination, reported researchers.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

The novel dual NK-1,3 receptor antagonist demonstrated statistically significant reduction in the frequency of moderate-to-severe VMS vs placebo.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.